Startup di de-extinction di Dallas che usa l'ingegneria genetica per riportare specie estinte (dodo, mammut).
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Funding round Colossal Biosciences raised another $120 million, pushing its valuation above $10.3 billion, for its avian de-extinction projects. | $120M |
| Jan 2023 | Series B Colossal Biosciences raised a $150M Series B led by US Innovative Technology Fund at a $1.5B valuation, with In-Q-Tel, Breyer Capital and others. | $150M |